Delivery Order 36F79719D0153-36C26023F0186
Award Date 3/1/23
Potential Completion Date 2/29/24
Potential Value $145K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Genzyme Corporation, a division of Sanofi Genzyme, to provide the drug CERDELGA. The contract has a potential value of $106,912.80 and a completion date of March 31, 2019. Genzyme is the prime contractor on this award, which was placed against the company's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, a multiple award schedule managed by the VA. The...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Genzyme Corporation, a division of Sanofi Genzyme, to provide the drug eliglustat for the VA's Puget Sound healthcare network. The order was placed against Genzyme's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, which has a potential value of $660 million over 5 years. This delivery order is valued at $106,985.22 and has a completion date of March...
- This is a $266,651.86 firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 (VISN 22) to Genzyme Corporation, a global pharmaceutical company doing business as Sanofi Genzyme. The order is for the specialty drug Eliglustat (Cerdelga) to support the VA's healthcare programs for veterans. The contract is issued under Genzyme's $659 million multiple-award Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with the VA,...
- This is a federal contract award for the delivery of the pharmaceutical product CERDELGA to the Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to the prime contractor Genzyme Corporation, a division of Sanofi Genzyme, on a firm fixed price basis. The contract has a potential value of $106,943.55 and was issued as a delivery order against Genzyme's existing Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA. The...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $236,944.32 firm fixed price delivery order to Genzyme Corporation, Sanofi Genzyme Therapeutics Division, for ELIGLUSTAT (CERDELGA) pharmaceutical products. The delivery order was issued against Genzyme's Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule contract vehicle and requires performance at the place of performance in San Diego, California. No set-aside designation was used...
- Genzyme Corporation, operating through its Sanofi Genzyme division and Genzyme Therapeutics business unit, has been awarded a $204,743.40 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) prime vendor contract vehicle. The order calls for the delivery of the drug eliglustat to the Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 in Cambridge, Massachusetts by February 25, 2021. No set-aside designation was applied to...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $265,045.04 firm fixed price delivery order to Genzyme Corporation, doing business under its Genzyme Therapeutics Division, for eliglustat medication. The period of performance is from October 1, 2020 to September 30, 2021. The delivery order was awarded against Genzyme Corporation's Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with performance taking...
- This is a federal contract award to Genzyme Corporation, doing business as Sanofi Genzyme, for pathology testing services. The $99,200.15 firm-fixed-price delivery order was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration under Genzyme's $659 million Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. This master contract allows the VA to issue task orders for a broad range of drug and pharmaceutical products over a 5-year period. Genzyme...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $212,340.40 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to Genzyme Corporation for the bulk purchase of 84mg oral capsules of Eliqlustat (Cerdelga). Performance will take place in Cambridge, Massachusetts with no set-aside designation applied. Genzyme Therapeutics Division, doing business as Sanofi Genzyme, will serve as the...
- This federal contract award is for the delivery of LEMTRADA INJECTION VIALS to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract was awarded to Genzyme Corporation, doing business as Sanofi Genzyme, a global healthcare and pharmaceutical company. It is a firm fixed price delivery order under Genzyme's $659 million Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, which allows the VHA to issue task orders for a...